Skip to main content
. 2016 Dec;71(12):703–708. doi: 10.6061/clinics/2016(12)05

Table 2.

Clinical and procedural data.

Results
n=22
Time from symptoms to embolization (weeks) (mean, range, SD) 59.6 (6-216, 48.6)
VAPS before embolization (mean, range, SD) 8.4 (4-10, 1.6)
VAPS after embolization (mean, range, SD) 5.2 (0-10, 3.2)
Time from embolization to VAPS (months) (mean, range, SD) 10.2 (3-24, 7.9)
Symptom improvement after embolization (n, %) 17 (77.3)
Minor complications (n, %) 4 (18.2)
n=21
Diameters of periuterine veins (mm) on MR before embolization (mean, range, SD) 6.7 (3-10, 1.6)
n=13
Diameters of periuterine veins (mm) on MR after embolization (mean, range, SD) 4.9 (2-7, 1.5)
n=12
Reduction of periuterine vein diameter after embolization (n, %) 8 (66.7)

Legend: (VAPS) Visual analog pain scale; (SD) Standard deviation; (MR) Magnetic resonance; (N) Patient number.